Pregnant women with obesity face elevated risks of complications during childbirth, including a higher likelihood of requiring a cesarean section (C-section). This surgical procedure, while sometimes necessary, carries its own set of risks for both mother and child. In a bid to address this issue, Dr. Jennifer Pierce, a physician-researcher at the University of Oklahoma, has received a $3.1 million grant from the National Institutes of Health (NIH) to lead a groundbreaking study. The multi-center clinical trial will investigate whether administering antibiotics at the beginning of labor induction can reduce the incidence of C-sections in this patient group. The study is believed to be the first large-scale clinical trial of its kind in the U.S.
Dr. Pierce’s research builds on the success of a previous pilot study that showed promising results. In that smaller trial, first-time pregnant women with obesity who received antibiotics at the start of labor induction experienced a 27% reduction in C-section delivery rates. These findings were published in the American Journal of Obstetrics and Gynecology MFM (Maternal-Fetal Medicine).
The underlying hypothesis is that antibiotics could reduce inflammation, a condition often exacerbated by obesity. Chronic low-grade inflammation is a known consequence of obesity, and labor itself triggers a state of inflammation in the body. Excessive inflammation can interfere with the function of the uterine muscles, potentially leading to labor abnormalities. Additionally, antibiotics may help address hidden infections—those that do not show symptoms like fever but may still interfere with the labor process.
While antibiotics are routinely prescribed prior to many surgeries, including C-sections, their use at the onset of labor induction is a relatively new concept. In this study, participants will be randomly assigned to receive either an antibiotic infusion of azithromycin or cefazolin, or a placebo, at the start of labor. The trial aims to determine whether this prophylactic approach can effectively reduce C-sections in women with obesity.
Beyond its primary goal, the study will also examine the impact of antibiotics on infection rates and other complications in both the mother and baby, with follow-up assessments conducted 30 days after delivery. Researchers will collect maternal blood and umbilical cord samples to explore how antibiotics might lower the risk of C-sections, as well as stool samples from both mother and child to assess changes in the microbiome. The microbiome, which consists of trillions of microorganisms in the intestines, plays a critical role in maintaining bodily health and may be influenced by antibiotic use.
This large-scale study aims to enroll nearly 800 pregnant women with obesity, and is a collaboration between several leading medical institutions, including Duke University, the University of Alabama at Birmingham, the University of Florida, and MetroHealth Medical Center, affiliated with Case Western University in Cleveland. The trial will span five years, with Dr. Pierce overseeing all aspects as the principal investigator.
“This is an exciting opportunity to develop a new intervention that can improve outcomes for pregnant women with obesity,” said Dr. Pierce. “Obesity remains a significant challenge for obstetricians, and the average BMI during pregnancy continues to rise. It is incredibly rewarding to be part of a team working toward a solution that could reduce complications and improve the health of both mother and baby.”
The study offers a promising potential benefit for pregnant women with obesity, but there are also challenges that need to be addressed. If successful, the intervention could help reduce the need for C-sections, which carry risks such as infection, longer recovery time, and complications in future pregnancies. However, it’s essential to recognize that antibiotics, while generally safe, can have side effects, including the development of antibiotic resistance or disruption of the microbiome. The trial’s comprehensive approach, including monitoring infection rates, maternal health, and microbiome changes, will provide important insights into the overall effectiveness and safety of this intervention.
In conclusion, while the study presents a novel and potentially impactful solution, its long-term effects on both maternal and infant health will be crucial in determining its feasibility as a standard practice for labor induction in women with obesity.
You Might Be Interested In:
-
History Of Concussion Identified As A Key Risk Factor For Maternal Mental Illness
-
Research Reveals Gaps In Maternal Care During Pregnancy In Australia
-
Babies Born To Mothers With Polycystic Ovary Syndrome And Obesity Have Smaller Body Sizes
